Recently GlyTherix’s CEO Brad Walsh shared an update on the company with Louise Weihart from Acuris Mergermarket.

Briefly, it was said that GlyTherix Ltd is seeking AUD 7M in a Series A equity round, after securing up to AUD 3M in non-dilutive funding from Round 9 of the Federal Government’s Cooperative Research Centres Projects (CRC-P) program, announced last week.

Download the full story.